| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |